Evidence Strategy
Design robust, actionable research strategies that are tailored to your unique goals, resources, and market realities. Together we ensure the strategy is aligned with both scientific rigor and business objectives.
Identify the right types of evidence - clinical, economic, or real-world - to support your business needs, and ensure your investments in research and dissemination will directly support regulatory, reimbursement, and market access decisions.
Ensure your strategy considers all the key stakeholders - clinicians, payers, patients, and regulators - when determining the appropriate research questions, endpoints, outcomes, and analysis type.
Determine how best to spread the results of research (and to whom) to produce the largest possible impact on your bottom line.
Paper Development
Receive expert support for developing peer-reviewed manuscripts, white papers, and other scientific communications, ensuring your work is publication-ready and positioned for maximum impact.
Collect and summarize information from relevant studies and reports to support your efforts and provide context for your research or clinical study.
Leverage the skills and experience of a PhD-level researcher to help you craft a compelling manuscript, develop informative tables, and create effective figures.
Rest easy knowing that the components and steps required for peer-review submission (and re-submission) are being tracked and documented, so nothing gets missed.
Value Demonstration
Leverage a proprietary framework and proven economic tools to identify, quantify, and communicate your unique value.
Identify and clearly identify your unique value through the Value Demonstration Framework developed by a PhD-level Health Economist.
Have analyses performed to quantify clinical, economic, and operational benefit, using the most appropriate methods for your unique situation. This can typically done using published research and existing data, avoiding the need for costly, time-consuming original data collection.
Translate results from economic analyses and complex financial evidence into compelling, audience-specific messages and materials. We can craft compelling, evidence-based narratives that support market access, investment, and clinical adoption.